PMDA — authorised 28 September 2012
- Marketing authorisation holder: Novo Nordisk Pharma Ltd
- Status: approved
PMDA authorised Tresiba on 28 September 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 28 September 2012.
Novo Nordisk Pharma Ltd holds the Japanese marketing authorisation.